Clara Health
Total Raised
$10.59MInvestors Count
16Deal Terms
2Funding, Valuation & Revenue
10 Fundings
Clara Health has raised $10.59M over 10 rounds.
Clara Health's latest funding round was a Acquired for on March 9, 2022.
Clara Health's valuation in February 2018 was $10M.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
3/9/2022 | Acquired | 1 | ||||
1/17/2020 | Series A | $7.09M | Undisclosed Investors | 1 | ||
9/26/2019 | Incubator/Accelerator | 1 | ||||
2/20/2018 | Seed VC - III | $10M | ||||
6/16/2017 | Grant |
Date | 3/9/2022 | 1/17/2020 | 9/26/2019 | 2/20/2018 | 6/16/2017 |
|---|---|---|---|---|---|
Round | Acquired | Series A | Incubator/Accelerator | Seed VC - III | Grant |
Amount | $7.09M | ||||
Investors | Undisclosed Investors | ||||
Valuation | $10M | ||||
Revenue | |||||
Sources | 1 | 1 | 1 |
Clara Health Deal Terms
2 Deal Terms
Clara Health's deal structure is available for 2 funding rounds, including their Seed VC - III from February 20, 2018.
Round | Seed VC - III | Pre-Seed |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Seed VC - III | |||||||||||||||
Pre-Seed |
Clara Health Investors
16 Investors
Clara Health has 16 investors. M&B Sciences invested in Clara Health's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
3/9/2022 | 3/9/2022 | 1 Acquired | Corporation | California | ||
9/26/2019 | 9/26/2019 | 1 Incubator/Accelerator | Incubator/Accelerator | |||
12/15/2016 | 2/20/2018 | 2 Pre-Seed, Seed VC - III (2018) | Angel Investor (Individual) | United States | ||
Venture Capital | California | |||||
Venture Capital | California |
First funding | 3/9/2022 | 9/26/2019 | 12/15/2016 | ||
|---|---|---|---|---|---|
Last Funding | 3/9/2022 | 9/26/2019 | 2/20/2018 | ||
Investor | |||||
Rounds | 1 Acquired | 1 Incubator/Accelerator | 2 Pre-Seed, Seed VC - III (2018) | ||
Board Seats | |||||
Type | Corporation | Incubator/Accelerator | Angel Investor (Individual) | Venture Capital | Venture Capital |
Location | California | United States | California | California |
Compare Clara Health to Competitors
Science 37 operates within the life sciences sector, providing solutions for patient access to clinical trials. The company's services aim to assist life sciences companies in conducting clinical research through various methods. It was founded in 2014 and is based in Morrisville, North Carolina. In March 2024, Science 37 was acquired by eMed at a valuation of $38M.
Castor operates within the healthcare sector and provides a clinical trial platform designed for the design, deployment, patient engagement, data collection, and analysis of clinical trials. The platform is adaptable and can meet the requirements of different stakeholders in the clinical research process. It primarily serves the healthcare sector. The company was founded in 2012 and is based in Amsterdam, Netherlands.
Antidote is involved in clinical trial patient recruitment within the healthcare and medical research sectors. The company provides recruitment services to assist clinical trial sponsors in filling trials and has a Match search engine to help patients find appropriate clinical trials. Antidote serves the healthcare industry with a focus on connecting patients to medical research opportunities. Antidote was formerly known as TrialReach. It was founded in 2010 and is based in North Miami Beach, Florida.
Formation Bio is an AI-native pharma company focused on drug development within the pharmaceutical industry. The company offers technology platforms designed to optimize clinical drug development, leading to trial design and completion. Formation Bio primarily serves the pharmaceutical and biotech sectors by acquiring clinical-stage drugs and enhancing their development process. It was founded in 2013 and is based in New York, New York.
Massive Bio operates as an artificial intelligence (AI) driven platform specializing in personalized oncology solutions within the healthcare sector. The company offers services connecting cancer patients and oncologists to clinical trials for new, alternative, and targeted treatments, as well as providing personalized treatment recommendations through a virtual tumor board. It primarily serves the healthcare industry, particularly oncology care providers and cancer patients seeking treatment options. It was founded in 2014 and is based in Istanbul, Turkey.
Evidation is a company that focuses on real-world health experiences and their implications within the life sciences sector. It offers a platform that collects continuous, multimodal data from individuals to inform model development, disease progression, treatment experience, and outcomes. Evidation serves the life sciences industry by providing data for research and evidence generation. It was founded in 2012 and is based in San Mateo, California.
Loading...